ArticleAesthetic plastic surgery2026
The Effect of Controlled Release Mixture of VEGF165 and Fibrin Sealant on Flap Preconditioning in a Rat Perforator Island Flap Model.
Article in Aesthetic plastic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFlap preconditioning enhances tissue vascularization and surgical outcomes by inducing angiogenesis. Vascular endothelial growth factor VEGF is a critical mediator; however, its short half-life limits standalone effectiveness. By incorporating VEGF into fibrin sealants (FS), controlled, localized release is achieved. Therefore, we hypothesized that preoperative administration of VEGF165 combined with fibrin sealant would enhance flap perfusion more effectively than VEGF165 alone.
methodsTwenty-four male Sprague-Dawley rats were assigned to four groups (n = 6 each). Control (phosphate-buffered saline), FS alone, VEGF165, and VEGF165 + FS. On Day 0 (T0), a 2 × 10 cm dorsal perforator flap was marked, and the panniculus carnosus was injected according to group assignment. After a 7-day preconditioning period (T7), the flaps, based on the dorsal circumflex iliac artery, were surgically elevated, repositioned, and perfusion was assessed via indocyanine green angiography. A follow-up angiography and tissue biopsy for immunofluorescence analyses were performed 7 days post-surgery (T14).
resultsAt T7, distal perfusion in the VEGF-treated groups was significantly higher than in the Control and FS groups (p < 0.001), with the VEGF + FS group outperforming VEGF alone (p < 0.05). At T14, both VEGF groups maintained superior perfusion compared to non-VEGF groups, and the VEGF + FS group exhibited a greater mature capillary density at the distal choke site (p < 0.05).
conclusionsPreoperative administration of VEGF165 with FS enhances distal flap perfusion and vascular maturation more effectively than VEGF165 alone, suggesting a promising strategy to improve perforator flap viability. NO LEVEL ASSIGNED: This journal requires that authors assign a level of evidence to each submission to which Evidence-Based Medicine rankings are applicable. This excludes Review Articles, Book Reviews, and manuscripts that concern Basic Science, Animal Studies, Cadaver Studies, and Experimental Studies. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Indexed as
Identifiers
41807626What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.